SCHEMBL7355343

SCHEMBL7355343

COc1ccc(S(=O)(=O)N(Cc2ccccc2)C2CCCCC2C(=O)O)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP1 P03956 2/20 0.81
▸ MMP9 P14780 2/20 0.81
▸ MMP13 P45452 2/20 0.81
▸ KCNA5 P22460 1/20 0.77
▸ TAS2R14 Q9NYV8 5/20 0.54
▸ PTGES O14684 2/20 0.52
▸ CXCR3 P49682 2/20 0.52
▸ TAS2R8 Q9NYW2 1/20 0.52
▸ CNR1 P21554 1/20 0.52
▸ CNR2 P34972 1/20 0.52
▸ ALDH1A1 P00352 2/20 0.50
▸ LMNA P02545 1/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ CAMK2A Q9UQM7 2/20 0.48
▸ TSHR P16473 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ ATM Q13315 1/20 0.48
▸ KEAP1 Q14145 1/20 0.48
▸ PSEN1 P49768 2/20 0.48
▸ PSEN2 P49810 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7379371 1.00 MMP1 (0.81) MMP1MMP9MMP13KCNA5TAS2R14
SCHEMBL7355335 1.00 MMP1 (0.81) MMP1MMP9MMP13KCNA5TAS2R14
SCHEMBL7355340 1.00 MMP1 (0.81) MMP1MMP9MMP13KCNA5TAS2R14
SCHEMBL7379373 1.00 MMP1 (0.81) MMP1MMP9MMP13KCNA5TAS2R14
Hydroxyamine SCHEMBL7457004 0.98 MMP1 (0.78) MMP1MMP9MMP13KCNA5TAS2R14
Hydroxyamine SCHEMBL7411103 0.98 MMP1 (0.78) MMP1MMP9MMP13KCNA5TAS2R14
Hydroxyamine SCHEMBL7411106 0.98 MMP1 (0.78) MMP1MMP9MMP13KCNA5TAS2R14
Hydroxyamine SCHEMBL7457010 0.98 MMP1 (0.78) MMP1MMP9MMP13KCNA5TAS2R14
Hydroxyamine SCHEMBL7411112 0.98 MMP1 (0.78) MMP1MMP9MMP13KCNA5TAS2R14
SCHEMBL7615080 0.90 MMP9 (1.00) MMP1MMP9MMP13KCNA5TAS2R14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0934259-B1 BETA-SULFONAMIDO HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS AMERICAN CYANAMID CO (US) 2002-09-18 — — EP disclosed
US-6326516-B1 RHEUMATIC DISEASES; SEPSIS; ANTIULCER AGENTS AMERICAN CYANAMID COMPANY 2001-12-04 — — US disclosed
EP-1147078-A1 ACETYLENIC (BETA)-SULFONAMIDO AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS American Cyanamid Company (US) 2001-10-24 — — EP disclosed
WO-2000044711-A1 ACETYLENIC $G(b)-SULFONAMIDO AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS AMERICAN CYANAMID COMPANY (US) 2000-08-03 — — WO disclosed
US-5977408-A USEFUL FOR THE TREATMENT OF DISEASES IN WHICH THESE ENZYMES ARE IMPLICATED SUCH AS ARTHRITIS, TUMOR GROWTH AND METASTASIS, ANGIOGENESIS, TISSUE ULCERATION, ABNORMAL WOUND HEALING, PERIODONTAL DISEASE, BONE DISEASE, PROTEINURIA AMERICAN CYANAMID COMPANY (US) 1999-11-02 — — US disclosed
EP-0934259-A1 BETA-SULFONAMIDO HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS American Cyanamid Company (US) 1999-08-11 — — EP disclosed
WO-1998016506-A1 BETA-SULFONAMIDO HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS AMERICAN CYANAMID COMPANY (US) 1998-04-23 — — WO disclosed
Send feedback